AAPL322.01-6.20 (-1.89%) ▼|ABBV256.00-4.22 (-1.62%) ▼|ABT109.00+0.21 (+0.19%) ▲|ACN187.09-6.04 (-3.13%) ▼|ADBE268.59-17.16 (-6.01%) ▼|AMAT452.21+16.30 (+3.74%) ▲|AMD471.72+15.56 (+3.41%) ▲|AMGN436.90-7.22 (-1.63%) ▼|AMT175.81-1.94 (-1.09%) ▼|AMZN258.26-0.65 (-0.25%) ▼|AVGO356.28-0.88 (-0.25%) ▼|AXP326.71-3.11 (-0.94%) ▼|BA211.69+1.18 (+0.56%) ▲|BAC62.64-0.08 (-0.13%) ▼|BKNG193.63-1.50 (-0.77%) ▼|BLK1,121.80-4.35 (-0.39%) ▼|BMY66.65-1.44 (-2.11%) ▼|BNY165.23+0.90 (+0.55%) ▲|BRK-B505.99-2.14 (-0.42%) ▼|C137.72-0.42 (-0.30%) ▼|CAT810.20+10.06 (+1.26%) ▲|CL89.04-1.05 (-1.17%) ▼|CMCSA26.51-0.14 (-0.53%) ▼|COF219.19-1.31 (-0.59%) ▼|COP134.48-1.24 (-0.91%) ▼|COST917.72-7.70 (-0.83%) ▼|CRM260.49-3.94 (-1.49%) ▼|CSCO109.30+0.69 (+0.64%) ▲|CVS96.97-0.23 (-0.24%) ▼|CVX208.44-2.88 (-1.36%) ▼|DE695.87+1.46 (+0.21%) ▲|DHR207.45-3.58 (-1.70%) ▼|DIS105.76-1.40 (-1.31%) ▼|DUK120.26-1.14 (-0.94%) ▼|EMR152.49+2.28 (+1.51%) ▲|FDX321.96-2.36 (-0.73%) ▼|GD358.54-7.33 (-2.00%) ▼|GE336.44+2.96 (+0.89%) ▲|GEV941.39-0.46 (-0.05%) ▼|GILD150.41-0.81 (-0.54%) ▼|GM87.45+0.41 (+0.47%) ▲|GOOG336.11-2.97 (-0.87%) ▼|GOOGL339.36-2.90 (-0.85%) ▼|GS1,036.76-1.18 (-0.11%) ▼|HD321.52+3.45 (+1.08%) ▲|HON208.64+1.01 (+0.48%) ▲|IBM234.35-0.36 (-0.15%) ▼|INTC94.71+3.04 (+3.32%) ▲|INTU332.41-11.89 (-3.45%) ▼|ISRG366.92-2.92 (-0.79%) ▼|JNJ275.37-3.07 (-1.10%) ▼|JPM358.04-4.02 (-1.11%) ▼|KO88.04-0.77 (-0.87%) ▼|LIN478.46-3.74 (-0.77%) ▼|LLY1,142.99-16.61 (-1.43%) ▼|LMT524.92-8.03 (-1.51%) ▼|LOW205.05+3.15 (+1.56%) ▲|LRCX303.28+10.62 (+3.63%) ▲|MA581.09-4.62 (-0.79%) ▼|MCD256.62-3.01 (-1.16%) ▼|MDLZ61.48+0.03 (+0.04%) ▲|MDT94.32+1.22 (+1.31%) ▲|META615.44+4.76 (+0.78%) ▲|MMM168.37+0.06 (+0.03%) ▲|MO69.00-0.50 (-0.71%) ▼|MRK150.28-2.06 (-1.35%) ▼|MS217.02-0.13 (-0.06%) ▼|MSFT500.11-10.01 (-1.96%) ▼|MU1,003.46+45.30 (+4.73%) ▲|NEE83.42-0.64 (-0.76%) ▼|NFLX78.76-3.92 (-4.74%) ▼|NKE38.57-0.21 (-0.53%) ▼|NOW141.24-4.35 (-2.99%) ▼|NVDA229.89+1.44 (+0.63%) ▲|ORCL156.89+2.85 (+1.85%) ▲|PEP137.85-0.70 (-0.50%) ▼|PFE28.42-0.39 (-1.35%) ▼|PG146.32-0.61 (-0.41%) ▼|PLTR174.25-8.28 (-4.54%) ▼|PM182.65-3.52 (-1.89%) ▼|QCOM167.28-1.29 (-0.77%) ▼|RTX200.65-1.48 (-0.73%) ▼|SBUX104.87-0.95 (-0.90%) ▼|SCHW109.47-0.91 (-0.82%) ▼|SO87.96-0.82 (-0.92%) ▼|SPG210.17-1.35 (-0.64%) ▼|T25.78-0.42 (-1.58%) ▼|TMO612.37-6.06 (-0.98%) ▼|TMUS182.89-5.13 (-2.73%) ▼|TSLA354.76-21.61 (-5.74%) ▼|TXN257.59+3.76 (+1.48%) ▲|UBER76.41+0.45 (+0.59%) ▲|UNH395.68-5.26 (-1.31%) ▼|UNP289.99+0.84 (+0.29%) ▲|UPS102.41-1.10 (-1.06%) ▼|USB63.37-0.17 (-0.26%) ▼|V374.63-4.12 (-1.09%) ▼|VZ50.27-0.33 (-0.64%) ▼|WFC89.82+0.63 (+0.71%) ▲|WMT107.32-1.10 (-1.01%) ▼|XOM159.78-2.44 (-1.50%) ▼|AAPL322.01-6.20 (-1.89%) ▼|ABBV256.00-4.22 (-1.62%) ▼|ABT109.00+0.21 (+0.19%) ▲|ACN187.09-6.04 (-3.13%) ▼|ADBE268.59-17.16 (-6.01%) ▼|AMAT452.21+16.30 (+3.74%) ▲|AMD471.72+15.56 (+3.41%) ▲|AMGN436.90-7.22 (-1.63%) ▼|AMT175.81-1.94 (-1.09%) ▼|AMZN258.26-0.65 (-0.25%) ▼|AVGO356.28-0.88 (-0.25%) ▼|AXP326.71-3.11 (-0.94%) ▼|BA211.69+1.18 (+0.56%) ▲|BAC62.64-0.08 (-0.13%) ▼|BKNG193.63-1.50 (-0.77%) ▼|BLK1,121.80-4.35 (-0.39%) ▼|BMY66.65-1.44 (-2.11%) ▼|BNY165.23+0.90 (+0.55%) ▲|BRK-B505.99-2.14 (-0.42%) ▼|C137.72-0.42 (-0.30%) ▼|CAT810.20+10.06 (+1.26%) ▲|CL89.04-1.05 (-1.17%) ▼|CMCSA26.51-0.14 (-0.53%) ▼|COF219.19-1.31 (-0.59%) ▼|COP134.48-1.24 (-0.91%) ▼|COST917.72-7.70 (-0.83%) ▼|CRM260.49-3.94 (-1.49%) ▼|CSCO109.30+0.69 (+0.64%) ▲|CVS96.97-0.23 (-0.24%) ▼|CVX208.44-2.88 (-1.36%) ▼|DE695.87+1.46 (+0.21%) ▲|DHR207.45-3.58 (-1.70%) ▼|DIS105.76-1.40 (-1.31%) ▼|DUK120.26-1.14 (-0.94%) ▼|EMR152.49+2.28 (+1.51%) ▲|FDX321.96-2.36 (-0.73%) ▼|GD358.54-7.33 (-2.00%) ▼|GE336.44+2.96 (+0.89%) ▲|GEV941.39-0.46 (-0.05%) ▼|GILD150.41-0.81 (-0.54%) ▼|GM87.45+0.41 (+0.47%) ▲|GOOG336.11-2.97 (-0.87%) ▼|GOOGL339.36-2.90 (-0.85%) ▼|GS1,036.76-1.18 (-0.11%) ▼|HD321.52+3.45 (+1.08%) ▲|HON208.64+1.01 (+0.48%) ▲|IBM234.35-0.36 (-0.15%) ▼|INTC94.71+3.04 (+3.32%) ▲|INTU332.41-11.89 (-3.45%) ▼|ISRG366.92-2.92 (-0.79%) ▼|JNJ275.37-3.07 (-1.10%) ▼|JPM358.04-4.02 (-1.11%) ▼|KO88.04-0.77 (-0.87%) ▼|LIN478.46-3.74 (-0.77%) ▼|LLY1,142.99-16.61 (-1.43%) ▼|LMT524.92-8.03 (-1.51%) ▼|LOW205.05+3.15 (+1.56%) ▲|LRCX303.28+10.62 (+3.63%) ▲|MA581.09-4.62 (-0.79%) ▼|MCD256.62-3.01 (-1.16%) ▼|MDLZ61.48+0.03 (+0.04%) ▲|MDT94.32+1.22 (+1.31%) ▲|META615.44+4.76 (+0.78%) ▲|MMM168.37+0.06 (+0.03%) ▲|MO69.00-0.50 (-0.71%) ▼|MRK150.28-2.06 (-1.35%) ▼|MS217.02-0.13 (-0.06%) ▼|MSFT500.11-10.01 (-1.96%) ▼|MU1,003.46+45.30 (+4.73%) ▲|NEE83.42-0.64 (-0.76%) ▼|NFLX78.76-3.92 (-4.74%) ▼|NKE38.57-0.21 (-0.53%) ▼|NOW141.24-4.35 (-2.99%) ▼|NVDA229.89+1.44 (+0.63%) ▲|ORCL156.89+2.85 (+1.85%) ▲|PEP137.85-0.70 (-0.50%) ▼|PFE28.42-0.39 (-1.35%) ▼|PG146.32-0.61 (-0.41%) ▼|PLTR174.25-8.28 (-4.54%) ▼|PM182.65-3.52 (-1.89%) ▼|QCOM167.28-1.29 (-0.77%) ▼|RTX200.65-1.48 (-0.73%) ▼|SBUX104.87-0.95 (-0.90%) ▼|SCHW109.47-0.91 (-0.82%) ▼|SO87.96-0.82 (-0.92%) ▼|SPG210.17-1.35 (-0.64%) ▼|T25.78-0.42 (-1.58%) ▼|TMO612.37-6.06 (-0.98%) ▼|TMUS182.89-5.13 (-2.73%) ▼|TSLA354.76-21.61 (-5.74%) ▼|TXN257.59+3.76 (+1.48%) ▲|UBER76.41+0.45 (+0.59%) ▲|UNH395.68-5.26 (-1.31%) ▼|UNP289.99+0.84 (+0.29%) ▲|UPS102.41-1.10 (-1.06%) ▼|USB63.37-0.17 (-0.26%) ▼|V374.63-4.12 (-1.09%) ▼|VZ50.27-0.33 (-0.64%) ▼|WFC89.82+0.63 (+0.71%) ▲|WMT107.32-1.10 (-1.01%) ▼|XOM159.78-2.44 (-1.50%) ▼|
29.8 C
New York
Friday, September 4, 2026

Tag: application

Beanfield and 1VALET Expand Partnership to Deliver a Connected Resident Experience Across Canadian Multi-Dwelling Communities

Non-exclusive integration connects Beanfield’s fibre Internet services with 1Valet’s smart building platform, enabling residents to access connectivity and building services through 1Valet’s single resident app, reducing friction for residents and property managers.
Non-exclusive integration connects Beanfield’s fibre Internet services with 1Valet’s smart building platform, enabling residents to access connectivity and building services through 1Valet’s single resident app, reducing friction for residents and property managers.

Beanfield et 1VALET étendent leur partenariat afin d’offrir une expérience connectée aux résidents dans les communautés d’immeubles multi-logements canadiens

Cette intégration non exclusive relie les services Internet par fibre optique de Beanfield à la plateforme de gestion intelligente des bâtiments de 1VALET, permettant ainsi aux résidents d’accéder à leur connectivité et aux services du bâtiment directement depuis l’application unique de 1VALET destinée aux résidents, ce qui simplifie la vie des résidents et des gestionnaires immobiliers.
Cette intégration non exclusive relie les services Internet par fibre optique de Beanfield à la plateforme de gestion intelligente des bâtiments de 1VALET, permettant ainsi aux résidents d’accéder à leur connectivité et aux services du bâtiment directement depuis l’application unique de 1VALET destinée aux résidents, ce qui simplifie la vie des résidents et des gestionnaires immobiliers.

Focusing on On-Chain-Native Prediction Markets: BM Wallet Launches Prediction Markets, Reimagining the Web3 User Experience

The launch debuts with a World Cup theme and an accompanying first-round rewards campaign. The feature also points to a larger ambition for BM Wallet: bringing scattered Web3 tools together into a single app that users truly control.
The launch debuts with a World Cup theme and an accompanying first-round rewards campaign. The feature also points to a larger ambition for BM Wallet: bringing scattered Web3 tools together into a single app that users truly control.

Waton Financial Launches MoTA Alpha, Marking Full Strategic Pivot to AI-Native Finance

HONG KONG, June 27, 2026 /PRNewswire/ -- Waton Financial Limited (NASDAQ: WTF) today announced the release of MoTA Alpha, a major upgrade to its...

CARE AT HOME GUARANTEE CORPORATION FILES PATENT APPLICATION FOR PROPRIETARY BUSINESS MANAGEMENT SYSTEM

Patent-Pending Designation Reflects Company's Commitment to Innovation and Protection of Its Proprietary Operational Processes
Patent-Pending Designation Reflects Company's Commitment to Innovation and Protection of Its Proprietary Operational Processes

Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing

HOUSTON, June 26, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the "Company" or "Decoy"), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™), a new...

/U P D A T E — Crown Capital Partners Inc./

This press release titled, Crown Capital Announces Anticipated Delay in Annual Filings and Application for Management Cease Trade Order issued by Crown Capital Partners...

Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results

LIKMEZ® (ATI-1501) commercial momentum building in U.S. market

US$40 million NIAID award supporting VXV-01 advancement through Phase 1

407 ETR marks Pollinator Week with native plant giveaway and expanded partnership with Canadian Wildlife Federation

$2 million investment supports habitat near the Highway 407 ETR corridor and beyond, helping protect monarch migration routes and strengthening regional biodiversity. TORONTO, June 26,...

The Inner Circle acknowledges Mary Jo Iozzio, PHD, STL, as a Pinnacle Professional member

WEST ROXBURY, Mass., June 26, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Mary Jo Iozzio, PHD, STL, is acknowledged as a Pinnacle...

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of...

WILMETTE, Ill., June 26, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, today announced that new analyses from the Phase 3 FoCus randomized controlled clinical trial of ALXN1840 (tiomolibdate choline, TMC) will be presented at the 12th Congress of the European Academy of Neurology (EAN 2026), June 27–30, 2026, in Geneva, Switzerland. These analyses build upon the previously reported Phase 3 FoCus results demonstrating ALXN1840 met its primary endpoint of superior copper mobilization versus standard of care.

Lantheus Receives Complete Response Letter from FDA for LNTH-2501 (Ga 68 edotreotide)

BEDFORD, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for LNTH-2501 (Gallium 68 edotreotide), a PET diagnostic imaging kit targeting somatostatin receptor-positive (SSTR+) neuroendocrine tumors (NETs). 

Sobi receives complete response letter from FDA for NASP (nanoencapsulated sirolimus plus pegadricase)

STOCKHOLM, June 26, 2026 /PRNewswire/ --The FDA has requested additional data related to chemistry, manufacturing, and controls (CMC) and contract manufacturing facilities; no clinical...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsApplication